Smead Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CB
CHUBB CORPORATION
CB
|
+$17.1M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$12.3M |
| 3 |
TGNA
TEGNA Inc
TGNA
|
+$6.83M |
| 4 |
eBay
EBAY
|
+$5.99M |
| 5 |
CAB
Cabela's Inc
CAB
|
+$5.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$17.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$10.3M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$2.16M |
| 4 |
Walt Disney
DIS
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.34% |
| 2 | Financials | 29.45% |
| 3 | Consumer Discretionary | 20.79% |
| 4 | Communication Services | 10.86% |
| 5 | Technology | 2.94% |
Similar funds
Smead Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, Smead Capital Management held 30 positions worth $830M, up 14% from $726M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Smead Capital Management deployed $81.9M of net new capital in Q1 2014, opening 1 new position and adding to 24 existing holdings. Its largest new stake was CHUBB CORPORATION: 195,561 shares worth $17.5M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $2.16M trimmed.
- Smead Capital Management's largest Q1 2014 buy was CHUBB CORPORATION: 195,561 shares worth $17.5M.
- Smead Capital Management added most to Berkshire Hathaway Class B in Q1 2014, an estimated $12.3M increase.
- Smead Capital Management's biggest Q1 2014 reduction was Walgreens Boots Alliance, cutting an estimated $2.16M.
- Smead Capital Management fully exited Viatris in Q1 2014, selling an estimated $17.9M.
- Smead Capital Management's ten largest holdings make up 52% of its $830M portfolio in Q1 2014.
- Smead Capital Management opened 1 new position and closed 2 in Q1 2014.
- Smead Capital Management's portfolio value rose 14% quarter-over-quarter to $830M.
Based on Smead Capital Management's 13F filing for Q1 2014, filed 8 May 2014.